newsfilter
← Latest News
Business Wire·

Graphite Bio Reports Recent Business Progress and Second Quarter 2021 Financial Results

On track to enroll first patient in Phase 1/2 clinical trial of GPH101 for sickle cell disease in the second half of 2021 Expanded leadership team with hiring of CSO and three new appointments to board of directors Completed upsized initial public